Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Multiple Myeloma|Breast Cancer
Interventions: DRUG: Zoledronic Acid
Sponsor: Vejle Hospital
Collaborators: Odense University Hospital|Novartis